Covered recipient · General Payments record
TOBIE BRESLOFF
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2020
$937.57
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2020 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $218.96 | 11 |
By paying entity
PY2020 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $112.39 | 4 |
| Novo Nordisk AS | $31.23 | 2 |
| Janssen Pharmaceuticals, Inc | $18.98 | 1 |
| Amgen Inc. | $15.99 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.03 | 1 |
| Currax Pharmaceuticals LLC | $12.88 | 1 |
| ABBVIE INC. | $12.46 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2020 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $12.46 | 02/18/2020 | Food and Beverage | Undisputed | 01/23/2026 | 721708133 | CMS |
| Amgen Inc. | $15.99 | 01/28/2020 | Food and Beverage | Undisputed | 01/23/2026 | 741339143 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.03 | 02/11/2020 | Food and Beverage | Undisputed | 01/23/2026 | 720854069 | CMS |
| Currax Pharmaceuticals LLC | $12.88 | 03/10/2020 | Food and Beverage | Undisputed | 01/23/2026 | 739106692 | CMS |
| Janssen Pharmaceuticals, Inc | $18.98 | 02/25/2020 | Food and Beverage | Undisputed | 01/23/2026 | 719459931 | CMS |
| Lilly USA, LLC | $8.88 | 01/23/2020 | Food and Beverage | Undisputed | 01/23/2026 | 728660137 | CMS |
| Lilly USA, LLC | $74.00 | 01/23/2020 | Food and Beverage | Undisputed | 01/23/2026 | 728663215 | CMS |
| Lilly USA, LLC | $14.80 | 01/23/2020 | Food and Beverage | Undisputed | 01/23/2026 | 728666681 | CMS |
| Lilly USA, LLC | $14.71 | 02/27/2020 | Food and Beverage | Undisputed | 01/23/2026 | 728680217 | CMS |
| Novo Nordisk Inc | $12.66 | 02/14/2020 | Food and Beverage | Undisputed | 01/23/2026 | 744622951 | CMS |
| Novo Nordisk Inc | $18.57 | 03/12/2020 | Food and Beverage | Undisputed | 01/23/2026 | 744640859 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020
- Generated from
- OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.